FDA tells Supreme Court to pass on Vanda’s fast-track status fightnews2025-10-16T16:47:56+00:00October 16th, 2025|Endpoints News|
Novartis’ Fabhalta gets confirmatory late-stage trial win in kidney disease IgANnews2025-10-16T13:03:03+00:00October 16th, 2025|Endpoints News|
J&J says Darzalex, Tecvayli combo improves survival odds in multiple myelomanews2025-10-16T12:00:04+00:00October 16th, 2025|Endpoints News|
Chicago biotech EVOQ pens $500M autoimmune pact with Sanofinews2025-10-16T10:07:32+00:00October 16th, 2025|Endpoints News|
BioNTech to get up to €95M in EU funding for a mRNA vaccine site in Africa news2025-10-15T16:07:33+00:00October 15th, 2025|Endpoints News|
Novo Nordisk buys kidney, blood disorder drug from Omerosnews2025-10-15T14:02:15+00:00October 15th, 2025|Endpoints News|
Pfizer claims first-line success for Tukysa in breast cancer Phase 3 trialnews2025-10-14T18:22:10+00:00October 14th, 2025|Endpoints News|
J&J CEO downplays any need for ‘large’ acquisition as it gears up for new launchesnews2025-10-14T17:41:05+00:00October 14th, 2025|Endpoints News|
Krystal Biotech wins second-ever FDA platform designation for viral vectornews2025-10-14T17:38:16+00:00October 14th, 2025|Endpoints News|
Supreme Court passes on fight over FDA stem cell regulationnews2025-10-14T16:07:37+00:00October 14th, 2025|Endpoints News|
